Written by Nick Ackerman, co-produced by Stanford Chemist
There has been considerable volatility this year, especially compared to last year's almost straight-up trajectory. With this, there have come some buying opportunities if one isn't too afraid to take the plunge. Those that did jump right in during March and April were rewarded with a swift rebound. This rebound is seemingly holding for now. We aren't out of the woods yet as far as COVID-19 related economic issues. However, we do still have some attractively valued funds at this time.
They are rated as a 'Buy'